{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T01:07:00Z","timestamp":1785546420022,"version":"3.56.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational Biology and Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.compbiolchem.2026.109197","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:33:36Z","timestamp":1781714016000},"page":"109197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Identification of natural MAO-B inhibitors with enhanced binding and dynamic stability: Implications for Parkinson\u2019s disease therapy"],"prefix":"10.1016","volume":"124","author":[{"given":"Mostafa","family":"Sayadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3072-7924","authenticated-orcid":false,"given":"Ali","family":"Ramazani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Zarei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiolchem.2026.109197_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2021.103057","article-title":"Synthesis, biological evaluation, molecular docking and in silico ADMET screening studies of novel isoxazoline derivatives from acridone","volume":"14","author":"Aarjane","year":"2021","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.compbiolchem.2026.109197_bib2","doi-asserted-by":"crossref","first-page":"70540","DOI":"10.1111\/cns.70540","article-title":"Levodopa and plant-derived bioactive compounds in parkinson's disease: mechanisms, efficacy, and future perspectives","volume":"31","author":"Akta\u015f","year":"2025","journal-title":"CNS Neurosci. & Ther."},{"key":"10.1016\/j.compbiolchem.2026.109197_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/1673-5374.375299","article-title":"Type-B monoamine oxidase inhibitors in neurological diseases: clinical applications based on preclinical findings","volume":"19","author":"Alborghetti","year":"2024","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.compbiolchem.2026.109197_bib4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40263-017-0408-1","article-title":"Safinamide: a review in Parkinson's disease","volume":"31","author":"Blair","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.compbiolchem.2026.109197_bib5","series-title":"Faculte des Sciences","article-title":"Ph. D. Thesis","author":"Bravo","year":"2009"},{"key":"10.1016\/j.compbiolchem.2026.109197_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111770","article-title":"Design of novel monoamine oxidase-B inhibitors based on piperine scaffold: structure-activity-toxicity, drug-likeness and efflux transport studies","volume":"185","author":"Chavarria","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2026.109197_bib7","unstructured":"Costa, A.Ld, Lima, H.B., Silva, A.C., Oliveira, G.S., Barcelos, M.P., Silva, C.Hd, Hage-Melim, L.I., 2024. J. Braz. Chem. Soc.36e-20240192."},{"key":"10.1016\/j.compbiolchem.2026.109197_bib8","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1038\/s41467-023-38410-y","article-title":"Peripheral modulation of antidepressant targets MAO-B and GABAAR by harmol induces mitohormesis and delays aging in preclinical models","volume":"14","author":"Costa-Machado","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.compbiolchem.2026.109197_bib9","doi-asserted-by":"crossref","first-page":"12684","DOI":"10.1073\/pnas.0505975102","article-title":"Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B","volume":"102","author":"De Colibus","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.compbiolchem.2026.109197_bib10","doi-asserted-by":"crossref","first-page":"17209","DOI":"10.1074\/jbc.M110920200","article-title":"Analysis of conserved active site residues in monoamine oxidase A and B and their three-dimensional molecular modeling","volume":"277","author":"Geha","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.compbiolchem.2026.109197_bib11","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","article-title":"Parkinson's disease and Parkinsonism","volume":"132","author":"Hayes","year":"2019","journal-title":"Am. J. Med."},{"key":"10.1016\/j.compbiolchem.2026.109197_bib12","doi-asserted-by":"crossref","first-page":"6789","DOI":"10.1080\/07391102.2022.2112082","article-title":"Identification of new small molecule monoamine oxidase-B inhibitors through pharmacophore-based virtual screening, molecular docking and molecular dynamics simulation studies","volume":"41","author":"Kumar","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.compbiolchem.2026.109197_bib13","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/s41598-024-51728-x","article-title":"Isatin-tethered halogen-containing acylhydrazone derivatives as monoamine oxidase inhibitor with neuroprotective effect","volume":"14","author":"Kumar","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiolchem.2026.109197_bib14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41387-024-00317-y","article-title":"Anti-obesity effect of irreversible MAO-B inhibitors in patients with Parkinson's disease","volume":"14","author":"Liang","year":"2024","journal-title":"Nutr. & Diabetes"},{"key":"10.1016\/j.compbiolchem.2026.109197_bib15","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1111\/j.1742-4658.2011.08386.x","article-title":"The 'gating' residues Ile199 and Tyr326 in human monoamine oxidase B function in substrate and inhibitor recognition","volume":"278","author":"Milczek","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.compbiolchem.2026.109197_bib16","first-page":"53","article-title":"Journal of neural transmission","author":"Nagatsu","year":"2006","journal-title":"Supplementum"},{"key":"10.1016\/j.compbiolchem.2026.109197_bib17","doi-asserted-by":"crossref","first-page":"11059","DOI":"10.3390\/ijms231911059","article-title":"Neuroprotective function of rasagiline and selegiline, inhibitors of type B monoamine oxidase, and role of monoamine oxidases in synucleinopathies","volume":"23","author":"Naoi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.compbiolchem.2026.109197_bib18","doi-asserted-by":"crossref","first-page":"8216","DOI":"10.1038\/s41467-025-63473-4","article-title":"Gut microbial production of imidazole propionate drives Parkinson's pathologies","volume":"16","author":"Park","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.compbiolchem.2026.109197_bib19","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1038\/s41467-024-48731-1","article-title":"Deep brain stimulation of symptom-specific networks in Parkinson's disease","volume":"15","author":"Rajamani","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.compbiolchem.2026.109197_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lfs.2019.03.057","article-title":"Parkinson's disease: mechanisms, translational models and management strategies","volume":"226","author":"Raza","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.compbiolchem.2026.109197_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1422080","article-title":"Identification of high-affinity Monoamine oxidase B inhibitors for depression and Parkinson's disease treatment: bioinformatic approach of drug repurposing","volume":"15","author":"Shahwan","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.compbiolchem.2026.109197_bib22","first-page":"29955","article-title":"Benchmarking different docking protocols for predicting the binding poses of ligands complexed with cyclooxygenase enzymes and screening chemical libraries","volume":"14","author":"Shamsian","year":"2024","journal-title":"S. Dastmalchi"},{"key":"10.1016\/j.compbiolchem.2026.109197_bib23","doi-asserted-by":"crossref","first-page":"21986","DOI":"10.1038\/srep21986","article-title":"Inhibitory effect of traditional oriental medicine-derived monoamine oxidase B inhibitor on radioresistance of non-small cell lung cancer","volume":"6","author":"Son","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiolchem.2026.109197_bib24","first-page":"477","article-title":"Monoamine oxidase-B inhibitors for the treatment of parkinson's disease: past, present, and future","volume":"12","author":"Tan","year":"2022","journal-title":"J. Park. \u2019S. Dis."},{"key":"10.1016\/j.compbiolchem.2026.109197_bib25","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41598-023-47069-w","article-title":"silico anti-alzheimer study of phytochemicals from Lamiaceae family through GSK3-\u03b2 inhibition","volume":"14","author":"Zareei","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiolchem.2026.109197_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2025.128088","article-title":"Dual inhibition of inflammatory mediators and Coronaviridae main proteases by 2,5-disubstituted 1,3,4-oxadiazoles: a computational study","volume":"435","author":"Zarei","year":"2025","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.compbiolchem.2026.109197_bib27","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1021\/acschemneuro.8b00313","article-title":"Development of adenosine A(2A) receptor antagonists for the treatment of parkinson's disease: a recent update and challenge","volume":"10","author":"Zheng","year":"2019","journal-title":"ACS Chem. Neurosci."}],"container-title":["Computational Biology and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927126003245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927126003245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:41:57Z","timestamp":1785541317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476927126003245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":27,"alternative-id":["S1476927126003245"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2026.109197","relation":{},"ISSN":["1476-9271"],"issn-type":[{"value":"1476-9271","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of natural MAO-B inhibitors with enhanced binding and dynamic stability: Implications for Parkinson\u2019s disease therapy","name":"articletitle","label":"Article Title"},{"value":"Computational Biology and Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2026.109197","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109197"}}